FDA Unveils New Platform for Tracking Side Effects

The new platform ‘will better serve agency scientists, researchers, and the public,’ the agency’s commissioner said.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The Food and Drug Administration on March 11 made public a new, consolidated platform for tracking side effects experienced by people following receipt of vaccines and drugs.

Officials are folding a number of existing platforms into the Adverse Event Monitoring System, which they are describing as a unified system that will be easier to search on.